Annamária Jakab - Concepedia

Author

Annamária Jakab

Hungarian Academy of Sciences

Also Known As

A Jakab, A. Jakab, Annamaria Jakab, Annamária Jakab, Jakab, A.

Publications

910

Citations

H-Index

Concepts

All Affiliations

Hungarian Academy of Sciences HUN-REN Research Centre for Natural Sciences Novartis Institutes for BioMedical Research Novartis (Switzerland)Eötvös Loránd University

About

Annamária Jakab is an author at Hungarian Academy of Sciences specializing in medicine, analytical chemistry, and chromatography.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	451
2	Biochemistry	4	4	165
3	Engineering	2	2	59
4	Health Sciences	2	2	121
5	Natural Sciences	2	2	44

Annamária Jakab

Publications

865

Citations

H-Index

Page 1

	Year	Citations
Comparative analysis of different plant oils by high-performance liquid chromatography–atmospheric pressure chemical ionization mass spectrometry Annamária Jakab, Károly Héberger, Esther Forgács Journal of Chromatography A Food ChemistryGas ChromatographyChemical CompositionMass SpectrometryDifferent Plant Oils	2002	132
Enhanced Mucosal Immunoglobulin A Response and Solid Protection against Foot-and-Mouth Disease Virus Challenge Induced by a Novel Dendrimeric Peptide Carolina Cubillos‐Zapata, Beatriz G. de la Torre, Annamária Jakab, Journal of Virology Novel Dendrimeric PeptideMucosal VaccinationVeterinary VaccineImmunologyAntiviral Response	2008	108
Quantification of the ratio of positional isomer dilinoleoyl‐oleoyl glycerols in vegetable oils Annamária Jakab, István Jablonkai, E. Forgács Rapid Communications in Mass Spectrometry Lipid AnalysisFood AnalysisLinoleic AcidFood ChemistryFatty Acids	2003	79
Differentiation of vegetable oils by mass spectrometry combined with statistical analysis Annamária Jakab, Krisztián Nagy, Károly Héberger, Rapid Communications in Mass Spectrometry	2002	78
Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial Martin Kaul, Peter End, Maciej Cabanski, Clinical and Translational Science	2021	74
Absorption, distribution, metabolism, and excretion of [14C]BYL719 (alpelisib) in healthy male volunteers Alexander D. James, Lars Blumenstein, Ulrike Glaenzel, Cancer Chemotherapy and Pharmacology Body CompositionBiochemistryHealthy Male VolunteersPhysiologyToxicology	2015	42
Polyethyleneglycol-Based Resins as Solid Supports for the Synthesis of Difficult or Long Peptides Beatriz G. de la Torre, Annamária Jakab, David Andreu International Journal of Peptide Research and Therapeutics EngineeringPeptide EngineeringPolymer SciencePeptide SynthesisPeptide Science	2007	39
Analysis of sterols by high‐performance liquid chromatography/mass spectrometry combined with chemometrics Kornél Nagy, Annamária Jakab, Ferenc Pollreisz, Rapid Communications in Mass Spectrometry	2006	38
Population pharmacokinetics and pharmacodynamics of<scp>BYL</scp>719, a phosphoinositide 3‐kinase antagonist, in adult patients with advanced solid malignancies Stefan S. De Buck, Annamária Jakab, Markus Boehm, British Journal of Clinical Pharmacology	2014	35
A Placebo‐Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa‐Induced Dyskinesia Claudia Trenkwalder, Daniela Berg, Olivier Rascol, Movement Disorders	2016	34

Page 1